TNF and neoplasm: Together with the recognition that effective tumor immunotherapy relies in part on overcoming T cell exhaustion (characterized in part by absence of TNF production) to augment the antitumoral T cell response (71), these observations support approaches aimed at augmenting T cell–derived TNF production in antitumor immunity.